← Back
Data updated: Mar 10, 2026
CHARTWELL
Infectious DiseaseDermatologyImmunology
CHARTWELL is a generic drug manufacturer focused on Infectious Disease, Dermatology, Immunology.
1973
Since
31
Drugs
-
Trials
631
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
DOXYCYCLINE HYCLATE 2026-02-19
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 38%
5 drugs
Dermatology 23%
3 drugs
Immunology 23%
3 drugs
Cardiovascular 8%
1 drugs
Respiratory 8%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Infectious Disease, Dermatology, Immunology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Immunology
Novartis big-pharma
Cardiovascular, Immunology, Respiratory
BAUSCH AND LOMB specialty
Cardiovascular, Infectious Disease, Dermatology, Immunology
APOTHECON specialty
Infectious Disease, Dermatology, Cardiovascular, Respiratory
Active (14)
Discontinued (17)
OXYCODONE AND ACETAMINOPHEN FLUCONAZOLE HYDROCODONE BITARTRATE AND ACETAMINOPHEN ACETAMINOPHEN AND CODEINE PHOSPHATE METFORMIN HYDROCHLORIDE SULFASALAZINE ALLOPURINOL AMOXICILLIN TERBINAFINE HYDROCHLORIDE MEMANTINE HYDROCHLORIDE DUTASTERIDE VIRILON FENOFIBRATE (MICRONIZED) CIPROFLOXACIN PHENDIMETRAZINE TARTRATE BENZPHETAMINE HYDROCHLORIDE METAPROTERENOL SULFATE
Company Info
- First Approval
- 1973-11-12
- Latest
- 2025-12-23
- Applications
- 38